Shenzhen Glory Medical (002551.SZ): Repurchase completed, a total of 2,999.47 million yuan was spent to repurchase 1,030,300 shares.

Shenzhen Glory Medical (002551.SZ) announced on June 7 that the deadline for the company's share buyback has expired as of the disclosure date of the announcement. As of the disclosure date of this announcement, the company has cumulatively repurchased 1,030,300 shares of the company's stock through the special securities account for repurchases in a centralized competitive bidding manner, accounting for 0.12% of the company's total share capital. The highest fill price was 3.10 yuan/share and the lowest fill price was 2.57 yuan/share, with a total amount paid of 2.99947 million yuan (excluding transaction fees).

Gelonghui FinanceJun 7 03:28

Shang Rong Healthcare: No downward revisions to the “Shang Rong Bonds” conversion price

Shenzhen Shangrong Medical Co., Ltd. issued an announcement. As of May 24, 2024, the company's stock had triggered a downward revision of the “Shangrong Bonds” conversion price, but the board of directors decided not to revise the share conversion price downward this time, and will not propose a correction plan within the next six months.

Zhitong FinanceMay 24 05:33

Shangrong Convertible Bonds: Expected to trigger downward correction conditions for share conversion prices

Shenzhen Shangrong Medical Co., Ltd. announced that from May 1, 2024, as of May 17, 2024, the closing price of the company's stock was lower than 90% of the current share conversion price for 10 consecutive trading days, which is expected to trigger downward correction conditions for the “Shangrong Bonds” conversion price.

Zhitong FinanceMay 17 03:29

Shangrong Medical (002551.SZ): Initial repurchase of 400,000 shares

Gelonghui, May 10, 丨 Shangrong Medical (002551.SZ) announced that on May 10, 2024, for the first time, the company repurchased 400,000 shares of the company's shares through a special stock repurchase securities account, accounting for 0.05% of the company's current total share capital (based on the company's total share capital as of May 9, 2024). The maximum transaction price was 3.10 yuan/share, and the minimum transaction price was 3.08 yuan/share. The total transaction amount was 1,236,000.00 yuan (excluding transaction fees).

Gelonghui FinanceMay 10 03:50

The China Securities Convertible Index opened down 0.02%. Among them, Shang Rong Convertible, Polaroid, Hangxin Convertible, Baichuan Transfer 2, and Jin Dan Convertible had the highest declines, falling 3.09%, 1.82%, 1.64%, 1.26%, and 1.1%, respectively.

The China Securities Convertible Index opened down 0.02%. Among them, Shang Rong Convertible, Polaroid, Hangxin Convertible, Baichuan Transfer 2, and Jin Dan Convertible had the highest declines, falling 3.09%, 1.82%, 1.64%, 1.26%, and 1.1%, respectively. In terms of growth, Kaineng Convertible Bonds, Tailin Convertible Bonds, Nootai Convertible Bonds, Mingdian Convertible Bonds, and Mingdian Transfer 02 had the highest gains, rising 13.74%, 10.38%, 1.15%, 1.1%, and 1.07%, respectively.

Zhitong FinanceMay 7 20:33

The medical device sector boosted Paulette's rise and stopped

Glonghui, May 7 | Paulette and Shangrong Medical rose and stopped, while Libang Instruments, Shanwaishan, Dongfulong, and Hong Kong Express Healthcare quickly followed suit. According to the news, the Health and Health Commission and eight other departments jointly issued “Opinions on Strengthening Capacity Building for Intensive Medicine Medical Services” on May 6. The opinion suggests that by the end of 2025, the number of intensive care beds nationwide will reach 15 beds/100,000 people, and the ratio of comprehensive ICU beds in relevant medical institutions will reach 1:0.8, and the bed care ratio will reach 1:3.

Gelonghui FinanceMay 6 20:34